Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

BACKGROUND: The search for immunological markers with ability of predicting clinical outcome is a priority in lymphomas, and in cancer in general. It is well known that some immunomodulatory cells, such as myeloid derived suppressor cells (MDSCs) or regulatory T cells (Tregs), are recruited by tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Cortegana, Carlos, Palazón-Carrión, Natalia, Martin Garcia-Sancho, Alejandro, Nogales-Fernandez, Esteban, Carnicero-González, Fernando, Ríos-Herranz, Eduardo, de la Cruz-Vicente, Fatima, Rodríguez-García, Guillermo, Fernández-Álvarez, Rubén, Rueda Dominguez, Antonio, Casanova-Espinosa, Maria, Martínez-Banaclocha, Natividad, Gumà-Padrò, Josep, Gómez-Codina, José, Labrador, Jorge, Salar-Silvestre, Antonio, Rodriguez-Abreu, Delvys, Galvez-Carvajal, Laura, Provencio, Mariano, Sánchez-Beato, Margarita, Guirado-Risueño, María, Espejo-García, Pablo, Lejeune, Marylene, Álvaro, Tomás, Sánchez-Margalet, Victor, de la Cruz-Merino, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728348/
https://www.ncbi.nlm.nih.gov/pubmed/34158317
http://dx.doi.org/10.1136/jitc-2020-002323

Ejemplares similares

Ejemplares similares